Status:
ACTIVE_NOT_RECRUITING
A Real-World Study of JT001 for COVID-19
Lead Sponsor:
Shanghai Vinnerna Biosciences Co., Ltd.
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Real-world disease outcomes and safety in patients with mild to moderate COVID-19 treated with JT001
Eligibility Criteria
Inclusion
- Age ≥18 years old.
- The novel coronavirus infection (COVID-19) meets at least one of the following five criteria:
- 1\) Diagnosis of novel coronavirus infection; 2) Diagnosed with novel coronavirus pneumonia; 3) The novel coronavirus nucleic acid test is positive; 4) Test positive for novel coronavirus antigen; 5) Culture positive for novel coronavirus.
- 3\. Patients who have not developed severe COVID-19 or died within 28 days of COVID-19 diagnosis, or who have developed severe COVID-19 or died within 28 days of COVID-19 diagnosis, were treated with deuterimodivir hydrobromide tablets or were not treated with anti-novel coronavirus before disease progression.
Exclusion
- · Patients who have not developed severe COVID-19 or died within 28 days of COVID-19 diagnosis, or those who have developed severe COVID-19 or died within 28 days of COVID-19 diagnosis, received the following anti-novel coronavirus treatments before disease progression, including: Nematavir tablet/Ritonavir tablet, Azvudine tablet, Monoravir capsule, Zenotavir tablet/Ritonavir tablet, Leritvir tablet, Ambavirzumab/Romisivir injection, human immunoglobulin for COVID-19 or convalescent plasma for COVID-19 survivors.
Key Trial Info
Start Date :
August 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
7656 Patients enrolled
Trial Details
Trial ID
NCT06142201
Start Date
August 31 2023
End Date
December 31 2024
Last Update
August 26 2024
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking university first hospital
Beijing, Beijing Municipality, China, 100034
2
Shanghai Fourth People's Hospital
Shanghai, Shanghai Municipality, China, 200000
3
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai, Shanghai Municipality, China, 200032
4
Gongli Hospital, Pudong New Area, Shanghai
Shanghai, Shanghai Municipality, China, 200135